Describe the clinical characteristics, paraclinical features, and treatment during hospitalization, as well as at 1, 3, and 12 months post-discharge, of heart failure patients at selected cardiovascular centers in Vietnam.
Study Design: Prospective cohort study Study Subjects: Patients discharged with a diagnosis of heart failure with reduced or mildly reduced ejection fraction. Inclusion Criteria: * Patients aged 18 years and older * Diagnosed with heart failure at the time of discharge * Have an ejection fraction (based on imaging modalities such as echocardiography or cardiac MRI) recorded closest to the time of discharge, showing a left ventricular ejection fraction of less than 50% Exclusion Criteria: * Patients and their relatives do not have means of communication with healthcare staff (phone, computer, messaging, etc.) * Patients do not reside in Vietnam after discharge Data Collection: * All patients meeting the criteria at the time of discharge during the study period will be continuously included. Information regarding demographic data, clinical presentation, biological markers, and in-hospital treatment characteristics will be collected using standardized data definitions from EuroHeart data standards for heart failure. * Periodically after hospital discharge (e.g., 1 month, 3 months, 12 months post-discharge), patients will be contacted by investigators to gather information on their current status, medications, and any cardiovascular events, including rehospitalizations, death, and current medical treatment. * Data entry will be performed using the REDCap project at the University of Medicine and Pharmacy, Ho Chi Minh City (https://redcap.umc.edu.vn/)
Study Type
OBSERVATIONAL
Enrollment
2,500
Optimal treatment using current National Guidelines for the diagnosis and treatment of chronic heart failure
University Medical Center Ho Chi Minh City
Ho Chi Minh City, Vietnam
RECRUITINGAll-cause mortality
Death from any cause
Time frame: 12 months
Heart failure rehospitalization
Patient rehospitalization due to cardiovascular causes, excluding apparent non-cardiac causes.
Time frame: 12 months
Major adverse cardiovascular events
Acute myocardial infarction, stroke or death from any cause
Time frame: 12 months
Guideline-directed medical therapy detail
Information regarding guideline-directed medical therapy, including medications used and dose titration over time.
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.